Advances in anticancer immunotoxin therapy.

Alewine, Christine; Hassan, Raffit; Pastan, Ira

Alewine, Christine; Hassan, Raffit; Pastan, Ira.

Afiliação

Alewine C; Laboratory of Molecular Biology and Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Hassan R; Laboratory of Molecular Biology and Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pastan I; Laboratory of Molecular Biology and Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA pastani@mail.nih.gov.

Oncologist ; 20(2): 176-85, 2015 Feb.

Article em En | MEDLINE | ID: mdl-25561510

Assuntos

Toxinas Bacterianas/uso terapêutico; Imunotoxinas/uso terapêutico; Neoplasias/tratamento farmacológico; Humanos; Neoplasias/imunologia; Neoplasias/patologia; Biossíntese de Proteínas/efeitos dos fármacos

Palavras-chave

Antibody conjugate; Antidrug antibody; Recombinant immunotoxin; Vascular leak syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxinas Bacterianas / Imunotoxinas / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google